Oral or intravenous methylprednisolone for acute relapses of MS?

Lancet

Volumn 349, Issue 9056, 1997, Pages 893-894

  Barkhof, F ^a   Polman, C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; METHYLPREDNISOLONE;

CLINICAL TRIAL; DRUG MEGADOSE; EDITORIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE SCLEROSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RELAPSE; SIDE EFFECT;

EID: 0030890416     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62691-8     Document Type: Note

References (5)

1. AJ Thompson C Kennard M Swash Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS Neurlogy 39 1989 969 971
2. DG Altman Practical statistics for medical research 1991 Chapman and Hall London 457
3. MN Milligan R Newcombe DAS Compston A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects J Neurol Neurosurg Psychiatry 50 1987 511 516
4. DH Miller PS Albert F Barkhof Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis Ann Neurol 39 1996 6 16
5. F Barkhof STFM Frequin OR Hommes A correlative triad of gadolinium-DTPA MRI, EDSS and CSF-MBP in relapsing multiple sclerosis patients treated with high dose intravenous methylprednisolone Neurology 42 1992 63 67